
Hong Kong Team Unveils Nasal Powder Stroke Treatment Aimed at the Minutes Before Hospital Care
Researchers at the University of Hong Kong say they have developed the first NanoPowder nasal spray for ischemic stroke, designed to bypass the blood-brain barrier and deliver treatment before hospital arrival.
- Researchers developed a NanoPowder nasal spray intended for prehospital ischemic stroke treatment.
- The delivery system uses a nose-to-brain pathway to bypass the blood-brain barrier.


